Showing results (51-60 of 254) with videos related to

Sort By:
Pageof 26
Antiviral Therapy|February 16, 2013
A boceprevir failure in a patient infected with HCV genotype 1g: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapyValeria Cento, Simona Landonio, Francesca De Luca, et al.
Antiviral Research|August 17, 2010
Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48h after the start of treatment with pegylated interferon and ribavirinGiustino Parruti, Ennio Polilli, Federica Sozio, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitorsValentina Svicher, Francesca Ceccherini-Silberstein, Fulvio Erba, et al.
Methods (San Diego, Calif.)|May 17, 2021
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartmentLorenzo Piermatteo, Rossana Scutari, Riccardo Chirichiello, et al.
Scandinavian Journal of Infectious Diseases|January 21, 2010
Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravirChiara Tommasi, Francesca Ceccherini-Silberstein, Roberta D'Arrigo, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 4, 2016
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian districtEnnio Polilli, Valeria Cento, Umberto Restelli, et al.
Journal of Chemical Information and Modeling|May 25, 2023
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an <i>In Silico</i> Drug Repurposing ApproachFrancesca Alessandra Ambrosio, Giosuè Costa, Isabella Romeo, et al.
Scientific Reports|April 9, 2024
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infectionLudovica Ferrari, Alessandra Ruggiero, Chiara Stefani, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 2, 2020
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesAnna Artese, Valentina Svicher, Giosuè Costa, et al.
Journal of the International AIDS Society|January 22, 2019
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohortAnnalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
Pageof 26